| Studying Tumor Samples From Young Patients With Neuroblastoma (NCT00907920) | Children's Oncology Group | 2008-12-01 |
| Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma (NCT00960739) | Centre Oscar Lambret | 2008-11-01 |
| A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma (NCT00743496) | St. Jude Children's Research Hospital | 2008-10-08 |
| Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification (NCT02864563) | Institut Curie | 2008-10-04 |
| Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors (NCT00788125) | City of Hope Medical Center | 2008-09-03 |
| Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL. (NCT00874315) | Nationwide Children's Hospital | 2008-09-01 |
| 131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma (NCT00798148) | Tehran University of Medical Sciences | 2008-09-01 |
| Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation (NCT00793351) | Samsung Medical Center | 2008-09-01 |
| MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors (NCT02444884) | Children's Oncology Group | 2008-09-01 |
| Blood Samples From Patients on a Clinical Trial to CINV During HSCT (NCT00900068) | OHSU Knight Cancer Institute | 2008-08-01 |
| The Role of Aromatic Hydrocarbon Receptor in the Tumorigenesis of Neuroblastoma and Its Relationship With MYCN Expression (NCT01075360) | National Taiwan University Hospital | 2008-08-01 |
| Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma (NCT00793845) | Samsung Medical Center | 2008-08-01 |
| High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma (NCT00389766) | Children's Cancer and Leukaemia Group | 2008-07-01 |
| A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer (NCT00754286) | Albert Einstein College of Medicine | 2008-07-01 |
| Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy (NCT00716976) | Children's Oncology Group | 2008-06-23 |
| Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma (NCT00698009) | M.D. Anderson Cancer Center | 2008-06-01 |
| A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells (NCT00703222) | Baylor College of Medicine | 2008-06-01 |
| Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases (NCT00813501) | City of Hope Medical Center | 2008-06-01 |
| A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families (NCT00782145) | Tufts Medical Center | 2008-06-01 |
| N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma (NCT00659984) | Molecular Insight Pharmaceuticals, Inc. | 2008-06-01 |
| Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma (NCT00644696) | University of Michigan Rogel Cancer Center | 2008-04-01 |
| Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma (NCT00392340) | Children's Cancer and Leukaemia Group | 2008-03-01 |
| Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma (NCT00601003) | Giselle Sholler | 2008-01-14 |
| The Role of Glycosyltransferases in the Oncogenesis of Neuroblastoma (NCT01058798) | National Taiwan University Hospital | 2008-01-01 |
| The Role of IMP3 Expression in Patients With Neuroblastoma (NCT01121419) | National Taiwan University Hospital | 2008-01-01 |
| Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma (NCT00499616) | Children's Oncology Group | 2007-10-08 |
| Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma (NCT00539500) | M.D. Anderson Cancer Center | 2007-10-01 |
| Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders (NCT00801931) | Columbia University | 2007-09-06 |
| The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients (NCT00726934) | Indiana University | 2007-09-01 |
| Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant (NCT00602446) | Masonic Cancer Center, University of Minnesota | 2007-08-01 |
| Evaluation of 18F-dopa and 123I-MIBG Uptake in the Patients With Neuroblastoma (NCT01943097) | National Taiwan University Hospital | 2007-06-01 |
| Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors (NCT00503724) | Pediatric Brain Tumor Consortium | 2007-06-01 |
| Ethanol-Lock Treatment in Preventing Central Venous Catheter Infections in Patients With High-Risk Neuroblastoma (NCT00471679) | Memorial Sloan Kettering Cancer Center | 2007-04-01 |
| Collecting and Storing Tissue From Young Patients With Cancer (NCT00898755) | Children's Oncology Group | 2007-03-05 |
| Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma (NCT00578864) | Baylor College of Medicine | 2007-03-01 |
| Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products (NCT00695279) | St. Jude Children's Research Hospital | 2007-01-04 |
| Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma (NCT00526318) | German Society for Pediatric Oncology and Hematology GPOH gGmbH | 2007-01-01 |
| Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients (NCT03042429) | University of Cologne | 2007-01-01 |
| N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma (NCT00509353) | New Approaches to Neuroblastoma Therapy Consortium | 2007-01-01 |
| Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant (NCT00900406) | Vanderbilt-Ingram Cancer Center | 2007-01-01 |
| HGS-ETR2 to Treat Children With Solid Tumors (NCT00428272) | National Cancer Institute (NCI) | 2006-12-04 |
| T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant (NCT00651716) | Vanderbilt-Ingram Cancer Center | 2006-12-01 |
| N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma (NCT00646230) | New Approaches to Neuroblastoma Therapy Consortium | 2006-12-01 |
| Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma (NCT00486564) | University of Vermont | 2006-11-01 |
| Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma (NCT00450827) | Memorial Sloan Kettering Cancer Center | 2006-08-01 |
| Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant (NCT00410657) | Fred Hutchinson Cancer Center | 2006-07-01 |
| A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation (NCT00405327) | University of Michigan Rogel Cancer Center | 2006-06-01 |
| Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma (NCT00107289) | Memorial Sloan Kettering Cancer Center | 2006-05-01 |
| Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant (NCT00324324) | OHSU Knight Cancer Institute | 2006-05-01 |
| Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation (NCT00336531) | Samsung Medical Center | 2006-04-01 |
| Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma (NCT00311584) | Children's Oncology Group | 2006-04-01 |
| Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors (NCT00624962) | Vanderbilt University | 2006-03-01 |
| N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma (NCT00295919) | New Approaches to Neuroblastoma Therapy Consortium | 2005-12-01 |
| Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors (NCT00303940) | National Institutes of Health Clinical Center (CC) | 2005-12-01 |
| Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma (NCT00492167) | Memorial Sloan Kettering Cancer Center | 2005-09-09 |
| ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors (NCT00132158) | St. Jude Children's Research Hospital | 2005-09-01 |
| Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma (NCT00126412) | GE Healthcare | 2005-08-02 |
| hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma (NCT00082758) | Children's Oncology Group | 2005-08-01 |
| Haploidentical Stem Cell Transplantation in Neuroblastoma (NCT00790413) | Lund University Hospital | 2005-08-01 |
| Therapy for Children With Neuroblastoma (NCT00135135) | St. Jude Children's Research Hospital | 2005-08-01 |
| Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer (NCT00349024) | Children's Cancer and Leukaemia Group | 2005-07-01 |
| Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma (NCT00202930) | Jean M. Tersak, M.D. | 2005-07-01 |
| ch14.18/CHO Bridging Study (NCT01704872) | St. Anna Kinderkrebsforschung | 2005-07-01 |
| Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma (NCT00450307) | Memorial Sloan Kettering Cancer Center | 2005-06-01 |
| Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma (NCT00040911) | Children's Oncology Group | 2005-04-01 |
| 131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma (NCT00293319) | University of California, San Francisco | 2005-04-01 |
| Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement (NCT00206388) | Baylor College of Medicine | 2005-04-01 |
| Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors (NCT00112645) | Milton S. Hershey Medical Center | 2005-04-01 |
| Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer (NCT00357500) | Dana-Farber Cancer Institute | 2005-01-01 |
| Campath-1H + FK506 and Methylprednisolone for GVHD (NCT00109993) | Case Comprehensive Cancer Center | 2005-01-01 |
| Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only (NCT00416559) | Children's Cancer and Leukaemia Group | 2004-12-01 |
| Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma (NCT00101309) | Milton S. Hershey Medical Center | 2004-11-01 |
| Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma (NCT00410631) | German Society for Pediatric Oncology and Hematology GPOH gGmbH | 2004-10-01 |
| Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant (NCT00293384) | Barbara Ann Karmanos Cancer Institute | 2004-10-01 |
| Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma (NCT00072488) | American College of Radiology Imaging Network | 2004-10-01 |
| Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment (NCT00089258) | Memorial Sloan Kettering Cancer Center | 2004-07-01 |
| N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma (NCT00093353) | New Approaches to Neuroblastoma Therapy Consortium | 2004-05-01 |
| Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation (NCT00080873) | Children's Oncology Group | 2004-04-01 |
| N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation (NCT00083135) | New Approaches to Neuroblastoma Therapy Consortium | 2004-03-01 |
| Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma (NCT00070200) | Children's Oncology Group | 2004-03-01 |
| Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer (NCT00089245) | Y-mAbs Therapeutics | 2004-02-05 |
| Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma (NCT00670410) | Columbia University | 2003-11-01 |
| Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases (NCT00084695) | Milton S. Hershey Medical Center | 2003-09-01 |
| Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease (NCT00118326) | Fred Hutchinson Cancer Center | 2003-08-01 |
| Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas (NCT00152126) | St. Jude Children's Research Hospital | 2003-08-01 |
| N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma (NCT00084422) | New Approaches to Neuroblastoma Therapy Consortium | 2003-08-01 |
| Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma (NCT00072358) | Memorial Sloan Kettering Cancer Center | 2003-07-01 |
| Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy (NCT00066599) | National Cancer Institute (NCI) | 2003-06-01 |
| Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation (NCT00064311) | National Institutes of Health Clinical Center (CC) | 2003-06-01 |
| Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma (NCT00276679) | Children's Cancer and Leukaemia Group | 2003-04-01 |
| Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients (NCT00085930) | Baylor College of Medicine | 2003-04-01 |
| Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma (NCT00098865) | Dana-Farber Cancer Institute | 2002-09-01 |
| ABT-751 in Treating Young Patients With Refractory Solid Tumors (NCT00036959) | National Institutes of Health Clinical Center (CC) | 2002-03-01 |
| Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer (NCT00053118) | Roswell Park Cancer Institute | 2002-03-01 |
| Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation (NCT00036712) | Medical College of Wisconsin | 2002-01-01 |
| Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors (NCT00049023) | O'Dorisio, M S | 2002-01-01 |
| Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma (NCT00030719) | University of Leicester | 2001-12-01 |
| Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma (NCT00037011) | Memorial Sloan Kettering Cancer Center | 2001-11-01 |
| Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy (NCT00030108) | National Institutes of Health Clinical Center (CC) | 2001-11-01 |
| Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9 (NCT00582608) | Memorial Sloan Kettering Cancer Center | 2001-10-01 |